This company listing is no longer active
Fuchs Past Earnings Performance
Past criteria checks 2/6
Fuchs's earnings have been declining at an average annual rate of -1.4%, while the Chemicals industry saw earnings growing at 2.4% annually. Revenues have been growing at an average rate of 6.2% per year. Fuchs's return on equity is 14.3%, and it has net margins of 7.5%.
Key information
-1.4%
Earnings growth rate
-1.5%
EPS growth rate
| Chemicals Industry Growth | 4.3% |
| Revenue growth rate | 6.2% |
| Return on equity | 14.3% |
| Net Margin | 7.5% |
| Next Earnings Update | 28 Jul 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Fuchs makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 23 | 3,540 | 265 | 628 | 69 |
| 31 Dec 22 | 3,412 | 259 | 614 | 67 |
| 30 Sep 22 | 3,284 | 254 | 602 | 65 |
| 30 Jun 22 | 3,100 | 245 | 584 | 61 |
| 31 Mar 22 | 2,982 | 249 | 567 | 59 |
| 31 Dec 21 | 2,871 | 253 | 554 | 57 |
| 30 Sep 21 | 2,767 | 275 | 539 | 56 |
| 30 Jun 21 | 2,669 | 277 | 524 | 55 |
| 31 Mar 21 | 2,459 | 240 | 504 | 53 |
| 31 Dec 20 | 2,378 | 220 | 495 | 52 |
| 30 Sep 20 | 2,360 | 194 | 491 | 52 |
| 30 Jun 20 | 2,396 | 195 | 492 | 52 |
| 31 Mar 20 | 2,545 | 224 | 505 | 53 |
| 31 Dec 19 | 2,572 | 228 | 502 | 53 |
| 30 Sep 19 | 2,566 | 245 | 498 | 54 |
| 30 Jun 19 | 2,552 | 260 | 494 | 53 |
| 31 Mar 19 | 2,567 | 276 | 487 | 54 |
| 31 Dec 18 | 2,567 | 288 | 482 | 52 |
| 30 Sep 18 | 2,564 | 290 | 478 | 50 |
| 30 Jun 18 | 2,537 | 275 | 475 | 50 |
| 31 Mar 18 | 2,498 | 270 | 472 | 47 |
| 31 Dec 17 | 2,473 | 269 | 471 | 47 |
| 30 Sep 17 | 2,426 | 266 | 466 | 48 |
| 30 Jun 17 | 2,378 | 266 | 461 | 46 |
| 31 Mar 17 | 2,335 | 266 | 456 | 45 |
| 31 Dec 16 | 2,267 | 259 | 446 | 44 |
| 30 Sep 16 | 2,243 | 246 | 443 | 42 |
| 30 Jun 16 | 2,207 | 244 | 434 | 43 |
| 31 Mar 16 | 2,136 | 238 | 419 | 41 |
| 31 Dec 15 | 2,079 | 236 | 406 | 39 |
| 30 Sep 15 | 2,002 | 236 | 391 | 37 |
| 30 Jun 15 | 1,954 | 233 | 378 | 35 |
| 31 Mar 15 | 1,902 | 224 | 367 | 33 |
| 31 Dec 14 | 1,866 | 220 | 356 | 33 |
| 30 Sep 14 | 1,855 | 217 | 352 | 33 |
| 30 Jun 14 | 1,841 | 216 | 347 | 32 |
| 31 Mar 14 | 1,846 | 219 | 347 | 32 |
| 31 Dec 13 | 1,832 | 218 | 345 | 31 |
| 30 Sep 13 | 1,819 | 215 | 340 | 30 |
| 30 Jun 13 | 1,819 | 212 | 340 | 30 |
| 31 Mar 13 | 1,813 | 207 | 339 | 29 |
| 31 Dec 12 | 1,819 | 206 | 337 | 29 |
| 30 Sep 12 | 1,791 | 202 | 333 | 30 |
Quality Earnings: 0B4R has high quality earnings.
Growing Profit Margin: 0B4R's current net profit margins (7.5%) are lower than last year (8.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0B4R's earnings have declined by 1.4% per year over the past 5 years.
Accelerating Growth: 0B4R's earnings growth over the past year (6.4%) exceeds its 5-year average (-1.4% per year).
Earnings vs Industry: 0B4R earnings growth over the past year (6.4%) did not outperform the Chemicals industry 52.5%.
Return on Equity
High ROE: 0B4R's Return on Equity (14.3%) is considered low.